Internal Medicine, Endocrinology, Diabetes, & Metabolism · Pueblo, CO
NPI
1649336546
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1303 Fortino Blvd Ste A
Pueblo, CO, 81008
Phone (719) 544-0052
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
267 services
Medicare patients, 2024
93
Average age 70
Drug cost, 2024
$726K
1,944 prescriptions
Company payments, 2025
$2.82
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Agha B Khan was code 99214 (office e&m - established), 128 times for 76 patients. In total Agha B Khan billed 267 services in 5 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 128 | 76 | $86.73 | $11K |
| 82962 Clinical Chemistry | Office | 102 | 48 | $3.21 | $327 |
| 99213 Office E&M - Established | Office | 17 | 13 | $72.69 | $1,236 |
| 99204 Office E&M - New | Office | 14 | 14 | $132.07 | $1,849 |
By year: 2022 $24K for 416 services; 2023 $19K for 331 services; 2024 $15K for 267 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 102 | 48 | $3.21 | $327 |
Medicare prescription drug claims, 2024
In 2024, the drug Agha B Khan prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 159 prescriptions and refills. In total Agha B Khan wrote 1,944 Medicare prescriptions that cost $726K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 159 | 274 | 32 | $12K |
| Levothyroxine Sodium Generic | 99 | 235 | 35 | $1,069 |
| Humulin R U-500 Insulin Regular, Human | 86 | 118 | 14 | $146K |
| Jardiance Empagliflozin | 83 | 186 | 26 | $110K |
| Metformin Hcl Generic | 72 | 160 | 26 | $491 |
| Novolog Mix 70-30 Flexpen Insulin Aspart Prot/Insuln Asp | 68 | 114 | 23 | $25K |
| Rosuvastatin Calcium Generic | 66 | 148 | 21 | $745 |
| Humalog Mix 75-25 Kwikpen Insulin Lispro Protamin/Lispro | 64 | 125 | 20 | $31K |
| Ozempic Semaglutide | 52 | 97 | 16 | $98K |
| Atorvastatin Calcium Generic | 50 | 127 | 24 | $464 |
| Methimazole Generic | 47 | 114 | 16 | $337 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 46 | 113 | 17 | $6,034 |
| Ezetimibe Generic | 43 | 99 | 13 | $1,232 |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 38 | 71 | 17 | $3,744 |
| Hydrochlorothiazide Generic | 34 | 54 | Under 11 | $98.98 |
Brand drugs: 940 claims; generic drugs: 726 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Agha B Khan $2.82 ($2.82 in general payments such as food, travel and fees) from 1 company. The largest payer was Beta Bionics, Inc. with $2.82.
| Company | Payments | Amount |
|---|---|---|
| Beta Bionics, Inc. BBNX | 1 | $2.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.